07/11/2017 - 12:53pm
The company now offers 25- and 35-mg dosage strengths of its generic of Focalin XR extended-release tablets. 
07/11/2017 - 12:45pm

Rachel Sher was most recently a senior policy analyst in the Food and Drug Administration’s Office of Policy.

07/06/2017 - 3:19pm

The approval adds to the 5-, 10-, 15-, 20- and 30-mg capsules the company has previously launched of the generic.

07/06/2017 - 1:47pm

Vigamox ophthalmic solution had U.S. sales of approximately $267.9 million, according to Quintiles IMS data for the 12 months ended March 2017.

07/05/2017 - 1:44pm

Advent International is buying the Mexican private generics leader from Endo for roughly $124 million. 

07/05/2017 - 12:45pm

The drug had annual market sales of $248 million for the 12 months ended April 2017.

06/30/2017 - 10:59am

Under the agreement, Sandoz will develop and commercialize a generic of a major inhaled combination therapy delivered using a pressurized metered dose inhaler that Vectura Group is developing. 

06/29/2017 - 4:57pm

The drug had combined sales of $188 million for the 12 months ended April 2017, the company said.

06/29/2017 - 3:11pm

The company said that the creams had combined U.S. sales of $38 million for the 12 months ended Aril 2017, according to QuintilesIMS data.